Gut microbiota mediates positive effects of liraglutide on dyslipidemia in mice fed a high-fat diet

Except for improving glycemic control, liraglutide, one of the glucagon-like peptide-1 receptor agonists, has exerted promising therapeutic effects for dyslipidemia. It has been proved that gut microbiota plays a dramatic role in regulating lipid metabolism. This study aims to explore whether liragl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li, Qiu, Yue, Zhang, Panpan, Wu, Xunan, Zhao, Zhicong, Deng, Xia, Yang, Ling, Wang, Dong, Yuan, Guoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835552/
https://www.ncbi.nlm.nih.gov/pubmed/36643973
http://dx.doi.org/10.3389/fnut.2022.1048693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835552/
https://www.ncbi.nlm.nih.gov/pubmed/36643973
http://dx.doi.org/10.3389/fnut.2022.1048693

Ejemplares similares